nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Abnormalities in resting-state EEG microstates are a vulnerability marker of migraine
|
Li, Yansong |
|
|
23 |
1 |
|
artikel |
2 |
A c-Fos activation map in nitroglycerin/levcromakalim-induced models of migraine
|
Wu, Shouyi |
|
|
23 |
1 |
|
artikel |
3 |
Alterations in metabolic flux in migraine and the translational relevance
|
Grech, Olivia |
|
|
23 |
1 |
|
artikel |
4 |
Alterations in pain processing circuitries in episodic migraine
|
Mungoven, Tiffani J. |
|
|
23 |
1 |
|
artikel |
5 |
Altered effective connectivity in migraine patients during emotional stimuli: a multi-frequency magnetoencephalography study
|
Ren, Jing |
|
|
23 |
1 |
|
artikel |
6 |
Altered functional connectivity of the right caudate nucleus in chronic migraine: a resting-state fMRI study
|
Yuan, Ziyu |
|
|
23 |
1 |
|
artikel |
7 |
Amplitude of low-frequency fluctuation after a single-trigger pain in patients with classical trigeminal neuralgia
|
Ge, Xiuhong |
|
|
23 |
1 |
|
artikel |
8 |
A phase 3, randomised, placebo-controlled study of erenumab for the prevention of chronic migraine in patients from Asia: the DRAGON study
|
Yu, Shengyuan |
|
|
23 |
1 |
|
artikel |
9 |
Applying a biopsychosocial model to migraine: rationale and clinical implications
|
Rosignoli, Chiara |
|
|
23 |
1 |
|
artikel |
10 |
A real-world study of acute and preventive medication use, adherence, and persistence in patients prescribed fremanezumab in the United States
|
Krasenbaum, Lynda J. |
|
|
23 |
1 |
|
artikel |
11 |
Assessment of peripheral biomarkers potentially involved in episodic and chronic migraine: a case-control study with a focus on NGF, BDNF, VEGF, and PGE2
|
Mozafarihashjin, Mohammad |
|
|
23 |
1 |
|
artikel |
12 |
Association between migraine and cognitive impairment
|
Gu, Lihua |
|
|
23 |
1 |
|
artikel |
13 |
A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan
|
Sakai, Fumihiko |
|
|
23 |
1 |
|
artikel |
14 |
A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine
|
Khanal, Saval |
|
|
23 |
1 |
|
artikel |
15 |
Attenuated alpha oscillation and hyperresponsiveness reveals impaired perceptual learning in migraineurs
|
Fong, Chun Yuen |
|
|
23 |
1 |
|
artikel |
16 |
Avoid or seek light – a randomized crossover fMRI study investigating opposing treatment strategies for photophobia in migraine
|
Matt, Eva |
|
|
23 |
1 |
|
artikel |
17 |
Behavioral and psychological factors in individuals with migraine without psychiatric comorbidities
|
Pistoia, Francesca |
|
|
23 |
1 |
|
artikel |
18 |
Brain barriers and their potential role in migraine pathophysiology
|
Wiggers, Astrid |
|
|
23 |
1 |
|
artikel |
19 |
Burden of tension-type headache in the Middle East and North Africa region, 1990-2019
|
Safiri, Saeid |
|
|
23 |
1 |
|
artikel |
20 |
Calcitonin gene-related peptide receptor antagonist BIBN4096BS regulates synaptic transmission in the vestibular nucleus and improves vestibular function via PKC/ERK/CREB pathway in an experimental chronic migraine rat model
|
Tian, Ruimin |
|
|
23 |
1 |
|
artikel |
21 |
Calcitonin gene-related peptide-targeting drugs and Raynaud’s phenomenon: a real-world potential safety signal from the WHO pharmacovigilance database
|
Gérard, Alexandre O. |
|
|
23 |
1 |
|
artikel |
22 |
Cardiac cephalalgia: a narrative review and ICHD-3 criteria evaluation
|
Navarro-Pérez, María Pilar |
|
|
23 |
1 |
|
artikel |
23 |
Central effects of galcanezumab in migraine: a pilot study on Steady State Visual Evoked Potentials and occipital hemodynamic response in migraine patients
|
de Tommaso, Marina |
|
|
23 |
1 |
|
artikel |
24 |
Cerebral blood flow alterations in migraine patients with and without aura: An arterial spin labeling study
|
Fu, Tong |
|
|
23 |
1 |
|
artikel |
25 |
Cerebral perfusion variance in new daily persistent headache and chronic migraine: an arterial spin-labeled MR imaging study
|
Bai, Xiaoyan |
|
|
23 |
1 |
|
artikel |
26 |
CGRP and PACAP-38 play an important role in diagnosing pediatric migraine
|
Liu, Junhui |
|
|
23 |
1 |
|
artikel |
27 |
CGRP-dependent sensitization of PKC-δ positive neurons in central amygdala mediates chronic migraine
|
Chou, Tse-Ming |
|
|
23 |
1 |
|
artikel |
28 |
CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury
|
Ashina, Håkan |
|
|
23 |
1 |
|
artikel |
29 |
Characterization of erenumab and rimegepant on calcitonin gene-related peptide induced responses in Xenopus Laevis oocytes expressing the calcitonin gene-related peptide receptor and the amylin-1 receptor
|
Hage La Cour, Sanne |
|
|
23 |
1 |
|
artikel |
30 |
Comment regarding: what is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta‑analysis of clinical trials
|
Han, Junhee |
|
|
23 |
1 |
|
artikel |
31 |
Comparing the relative and absolute effect of erenumab: is a 50% response enough? Results from the ESTEEMen study
|
Ornello, Raffaele |
|
|
23 |
1 |
|
artikel |
32 |
Contribution of tetrodotoxin-resistant persistent Na+ currents to the excitability of C-type dural afferent neurons in rats
|
Nakamura, Michiko |
|
|
23 |
1 |
|
artikel |
33 |
Correction: Applying a biopsychosocial model to migraine: rationale and clinical implications
|
Rosignoli, Chiara |
|
|
23 |
1 |
|
artikel |
34 |
Correction: A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan
|
Sakai, Fumihiko |
|
|
23 |
1 |
|
artikel |
35 |
Correction: Burden of tension-type headache in the Middle East and North Africa region, 1990-2019
|
Safiri, Saeid |
|
|
23 |
1 |
|
artikel |
36 |
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
|
Nahas, Stephanie J. |
|
|
23 |
1 |
|
artikel |
37 |
Correction: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
|
Barbanti, Piero |
|
|
23 |
1 |
|
artikel |
38 |
Correction: Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
|
Gantenbein, Andreas R. |
|
|
23 |
1 |
|
artikel |
39 |
Correction: The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
|
Ruscheweyh, Ruth |
|
|
23 |
1 |
|
artikel |
40 |
Correction to: Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
|
Barbanti, Piero |
|
|
23 |
1 |
|
artikel |
41 |
Correction to: Hyperbaric oxygen attenuates neuropathic pain and reverses inflammatory signaling likely via the Kindlin-1/Wnt-10a signaling pathway in the chronic pain injury model in rats
|
Zhao, Baisong |
|
|
23 |
1 |
|
artikel |
42 |
Correction to: Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists
|
Krivoshein, G. |
|
|
23 |
1 |
|
artikel |
43 |
Cortical spreading depression can be triggered by sensory stimulation in primed wild type mouse brain: a mechanistic insight to migraine aura generation
|
Hanalioglu, Sahin |
|
|
23 |
1 |
|
artikel |
44 |
Cortical spreading depression induces propagating activation of the thalamus ventral posteromedial nucleus in awake mice
|
Fu, Xiaoxi |
|
|
23 |
1 |
|
artikel |
45 |
Cranial autonomic symptoms: prevalence, phenotype and laterality in migraine and two potentially new symptoms
|
Karsan, Nazia |
|
|
23 |
1 |
|
artikel |
46 |
Debate: Are cluster headache and migraine distinct headache disorders?
|
Al-Karagholi, Mohammad Al-Mahdi |
|
|
23 |
1 |
|
artikel |
47 |
De novo headache in ischemic stroke patients treated with thrombectomy: a prospective study
|
Gallo, Daniel |
|
|
23 |
1 |
|
artikel |
48 |
Development and validation of a novel model for characterizing migraine outcomes within real-world data
|
Hindiyeh, Nada A. |
|
|
23 |
1 |
|
artikel |
49 |
Diagnostic criteria for acute headache attributed to ischemic stroke and for sentinel headache before ischemic stroke
|
Lebedeva, Elena R. |
|
|
23 |
1 |
|
artikel |
50 |
Disease- and headache-specific microRNA signatures and their predicted mRNA targets in peripheral blood mononuclear cells in migraineurs: role of inflammatory signalling and oxidative stress
|
Aczél, Timea |
|
|
23 |
1 |
|
artikel |
51 |
Does MIDAS reduction at 3 months predict the outcome of erenumab treatment? A real-world, open-label trial
|
De Icco, Roberto |
|
|
23 |
1 |
|
artikel |
52 |
Dopamine receptor D2 regulates GLUA1-containing AMPA receptor trafficking and central sensitization through the PI3K signaling pathway in a male rat model of chronic migraine
|
Zhang, Wei |
|
|
23 |
1 |
|
artikel |
53 |
Dual action of the cannabinoid receptor 1 ligand arachidonyl-2′-chloroethylamide on calcitonin gene-related peptide release
|
Christiansen, Isabella Mai |
|
|
23 |
1 |
|
artikel |
54 |
Dynamic brainstem and somatosensory cortical excitability during migraine cycles
|
Hsiao, Fu-Jung |
|
|
23 |
1 |
|
artikel |
55 |
Early onset of efficacy with fremanezumab in patients with episodic and chronic migraine: subanalysis of two phase 2b/3 trials in Japanese and Korean patients
|
Takeshima, Takao |
|
|
23 |
1 |
|
artikel |
56 |
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine
|
Buse, Dawn C. |
|
|
23 |
1 |
|
artikel |
57 |
Effectiveness and acceptability of noninvasive brain and nerve stimulation techniques for migraine prophylaxis: a network meta-analysis of randomized controlled trials
|
Cheng, Yu-Chen |
|
|
23 |
1 |
|
artikel |
58 |
Effects of a history of headache and migraine treatment on baseline neurocognitive function in young athletes
|
McCarthy, Lily |
|
|
23 |
1 |
|
artikel |
59 |
Effects of eptinezumab on self-reported work productivity in adults with migraine and prior preventive treatment failure in the randomized, double-blind, placebo-controlled DELIVER study
|
Barbanti, Piero |
|
|
23 |
1 |
|
artikel |
60 |
Efficacy and safety of monoclonal antibody against calcitonin gene-related peptide or its receptor for migraine patients with prior preventive treatment failure: a network meta-analysis
|
Wang, Xing |
|
|
23 |
1 |
|
artikel |
61 |
Efficacy of erenumab and factors predicting response after 3 months in treatment resistant chronic migraine: a clinical service evaluation
|
Lowe, Michael |
|
|
23 |
1 |
|
artikel |
62 |
Efficacy profile of noninvasive vagus nerve stimulation on cortical spreading depression susceptibility and the tissue response in a rat model
|
Liu, Tzu-Ting |
|
|
23 |
1 |
|
artikel |
63 |
Enhanced pain facilitation rather than impaired pain inhibition in burning mouth syndrome female patients
|
Gremeau-Richard, Christelle |
|
|
23 |
1 |
|
artikel |
64 |
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study
|
McAllister, Peter |
|
|
23 |
1 |
|
artikel |
65 |
Erenumab versus topiramate: post hoc efficacy analysis from the HER-MES study
|
Ehrlich, Marc |
|
|
23 |
1 |
|
artikel |
66 |
European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
|
Sacco, Simona |
|
|
23 |
1 |
|
artikel |
67 |
European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
|
Sacco, Simona |
|
|
23 |
1 |
|
artikel |
68 |
Exploring alterations in sensory pathways in migraine
|
Meylakh, Noemi |
|
|
23 |
1 |
|
artikel |
69 |
Exploring the neurobiology of the premonitory phase of migraine preclinically – a role for hypothalamic kappa opioid receptors?
|
Kopruszinski, Caroline M. |
|
|
23 |
1 |
|
artikel |
70 |
Expression of vasopressin and its receptors in migraine-related regions in CNS and the trigeminal system: influence of sex
|
Maddahi, Aida |
|
|
23 |
1 |
|
artikel |
71 |
FKN/CX3CR1 axis facilitates migraine-Like behaviour by activating thalamic-cortical network microglia in status epilepticus model rats
|
Zhou, Yanjie |
|
|
23 |
1 |
|
artikel |
72 |
Fremanezumab in the prevention of high-frequency episodic and chronic migraine: a 12-week, multicenter, real-life, cohort study (the FRIEND study)
|
Barbanti, Piero |
|
|
23 |
1 |
|
artikel |
73 |
Functional connectivity and structural changes of thalamic subregions in episodic migraine
|
Yang, Ying |
|
|
23 |
1 |
|
artikel |
74 |
Functional improvement in children and adolescents with primary headache after an interdisciplinary multimodal therapy program: the DreKiP study
|
Sobe, Hanna |
|
|
23 |
1 |
|
artikel |
75 |
Functionality, satisfaction, and global impression of change with ubrogepant for the acute treatment of migraine in triptan insufficient responders: a post hoc analysis of the ACHIEVE I and ACHIEVE II randomized trials
|
Lipton, Richard B. |
|
|
23 |
1 |
|
artikel |
76 |
Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
|
Silvestro, Marcello |
|
|
23 |
1 |
|
artikel |
77 |
Galcanezumab in episodic migraine: the phase 3, randomized, double-blind, placebo-controlled PERSIST study
|
Hu, Bo |
|
|
23 |
1 |
|
artikel |
78 |
Gamma-aminobutyric acid and glutamate/glutamine levels in the dentate nucleus and periaqueductal gray with episodic and chronic migraine: a proton magnetic resonance spectroscopy study
|
Wang, Wei |
|
|
23 |
1 |
|
artikel |
79 |
Genome-wide analyses identify novel risk loci for cluster headache in Han Chinese residing in Taiwan
|
Chen, Shih-Pin |
|
|
23 |
1 |
|
artikel |
80 |
Genome-wide analysis identified novel susceptible genes of restless legs syndrome in migraineurs
|
Jiang, Yun-Jin |
|
|
23 |
1 |
|
artikel |
81 |
Gradually shifting clinical phenomics in migraine spectrum: a cross-sectional, multicenter study of 5438 patients
|
Ran, Ye |
|
|
23 |
1 |
|
artikel |
82 |
Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study
|
Sampaio Rocha-Filho, Pedro Augusto |
|
|
23 |
1 |
|
artikel |
83 |
Headache onset after vaccination against SARS-CoV-2: a systematic literature review and meta-analysis
|
Castaldo, Matteo |
|
|
23 |
1 |
|
artikel |
84 |
Headache-related circuits and high frequencies evaluated by EEG, MRI, PET as potential biomarkers to differentiate chronic and episodic migraine: Evidence from a systematic review
|
Gomez-Pilar, Javier |
|
|
23 |
1 |
|
artikel |
85 |
HMGB1 in the mPFC governs comorbid anxiety in neuropathic pain
|
Du, Yu |
|
|
23 |
1 |
|
artikel |
86 |
Hypoperfusion in nucleus accumbens in chronic migraine using 3D pseudo-continuous arterial spin labeling imaging MRI
|
Liu, Mengqi |
|
|
23 |
1 |
|
artikel |
87 |
IL-17 crosses the blood–brain barrier to trigger neuroinflammation: a novel mechanism in nitroglycerin-induced chronic migraine
|
Chen, Hao |
|
|
23 |
1 |
|
artikel |
88 |
Imaging the inflammatory phenotype in migraine
|
Christensen, Rune Häckert |
|
|
23 |
1 |
|
artikel |
89 |
Impact of fremanezumab on disability outcomes in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies
|
McAllister, Peter |
|
|
23 |
1 |
|
artikel |
90 |
Increased risk of all-cause, Alzheimer’s, and vascular dementia in adults with migraine in Korea: a population-based cohort study
|
Hurh, Kyungduk |
|
|
23 |
1 |
|
artikel |
91 |
Insular functional connectivity in migraine with aura
|
Gollion, Cédric |
|
|
23 |
1 |
|
artikel |
92 |
Insulin sensitizes neural and vascular TRPV1 receptors in the trigeminovascular system
|
Rosta, Judit |
|
|
23 |
1 |
|
artikel |
93 |
Interictal osmophobia is associated with longer migraine disease duration
|
Gossrau, Gudrun |
|
|
23 |
1 |
|
artikel |
94 |
Involvement of adenosine signaling pathway in migraine pathophysiology: a systematic review of preclinical studies
|
Thuraiaiyah, Janu |
|
|
23 |
1 |
|
artikel |
95 |
Lasmiditan and 5-Hydroxytryptamine in the rat trigeminal system; expression, release and interactions with 5-HT1 receptors
|
Edvinsson, Jacob C. A. |
|
|
23 |
1 |
|
artikel |
96 |
Long COVID headache
|
Tana, Claudio |
|
|
23 |
1 |
|
artikel |
97 |
Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab
|
Schwedt, Todd J. |
|
|
23 |
1 |
|
artikel |
98 |
Long term evaluation of a multidisciplinary trigeminal neuralgia service
|
Singhota, Sanjeet |
|
|
23 |
1 |
|
artikel |
99 |
Measuring dose-related efficacy of eptinezumab for migraine prevention: post hoc analysis of PROMISE-1 and PROMISE-2
|
Apelian, Rami |
|
|
23 |
1 |
|
artikel |
100 |
Measuring interictal burden among people affected by migraine: a descriptive survey study
|
Hubig, Lena T. |
|
|
23 |
1 |
|
artikel |
101 |
Microvascular decompression in trigeminal neuralgia - a prospective study of 115 patients
|
Andersen, Anne Sofie Schott |
|
|
23 |
1 |
|
artikel |
102 |
Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting
|
Peles, Ido |
|
|
23 |
1 |
|
artikel |
103 |
Migraine-relevant sex-dependent activation of mouse meningeal afferents by TRPM3 agonists
|
Krivoshein, G. |
|
|
23 |
1 |
|
artikel |
104 |
Migraine susceptibility is modulated by food triggers and analgesic overuse via sulfotransferase inhibition
|
Vuralli, Doga |
|
|
23 |
1 |
|
artikel |
105 |
Monthly migraine days, tablet utilization, and quality of life associated with Rimegepant – post hoc results from an open label safety study (BHV3000–201)
|
Johnston, Karissa |
|
|
23 |
1 |
|
artikel |
106 |
Narrative-based medicine in headache disorders
|
Lampl, Christian |
|
|
23 |
1 |
|
artikel |
107 |
One-quarter of individuals with weekly headache have never consulted a medical doctor: a Danish nationwide cross-sectional survey
|
Do, Thien Phu |
|
|
23 |
1 |
|
artikel |
108 |
Optimization of acute medication use following eptinezumab initiation during a migraine attack: post hoc analysis of the RELIEF study
|
Cady, Roger |
|
|
23 |
1 |
|
artikel |
109 |
PACAP signaling is not involved in GTN- and levcromakalim-induced hypersensitivity in mouse models of migraine
|
Guo, Song |
|
|
23 |
1 |
|
artikel |
110 |
Patient-reported outcomes, health-related quality of life, and acute medication use in patients with a ≥ 75% response to eptinezumab: subgroup pooled analysis of the PROMISE trials
|
Lipton, Richard B. |
|
|
23 |
1 |
|
artikel |
111 |
Persistence, use of resources and costs in patients under migraine preventive treatment: the PERSEC study
|
Irimia, Pablo |
|
|
23 |
1 |
|
artikel |
112 |
Persistent headache after first-ever ischemic stroke: clinical characteristics and factors associated with its development
|
Lebedeva, Elena R. |
|
|
23 |
1 |
|
artikel |
113 |
Post-COVID-19 neuropsychiatric manifestations among COVID-19 survivors suffering from migraine: a case–control study
|
Magdy, Rehab |
|
|
23 |
1 |
|
artikel |
114 |
Post-traumatic headache after mild traumatic brain injury in a one-year follow up study – risk factors and return to work
|
Kraemer, Yvonn |
|
|
23 |
1 |
|
artikel |
115 |
Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine
|
Greco, Rosaria |
|
|
23 |
1 |
|
artikel |
116 |
Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patients
|
Li, Ke |
|
|
23 |
1 |
|
artikel |
117 |
Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients
|
Barbanti, Piero |
|
|
23 |
1 |
|
artikel |
118 |
Premonitory symptoms in migraine: a systematic review and meta-analysis of observational studies reporting prevalence or relative frequency
|
Eigenbrodt, Anna K. |
|
|
23 |
1 |
|
artikel |
119 |
Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study
|
Crowe, Holly M. |
|
|
23 |
1 |
|
artikel |
120 |
Preventive treatment can reverse cognitive impairment in chronic migraine
|
González-Mingot, Cristina |
|
|
23 |
1 |
|
artikel |
121 |
Prolonged migraine aura resembling ischemic stroke following CoronaVac vaccination: an extended case series
|
Suwanwela, Nijasri C. |
|
|
23 |
1 |
|
artikel |
122 |
Provoked versus spontaneous migraine attacks: pathophysiological similarities and differences
|
Ashina, Håkan |
|
|
23 |
1 |
|
artikel |
123 |
P2X7R/NLRP3 signaling pathway-mediated pyroptosis and neuroinflammation contributed to cognitive impairment in a mouse model of migraine
|
Wang, Yajuan |
|
|
23 |
1 |
|
artikel |
124 |
Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study
|
Cowan, Robert P. |
|
|
23 |
1 |
|
artikel |
125 |
Real-world effectiveness after initiating fremanezumab treatment in US patients with episodic and chronic migraine or difficult-to-treat migraine
|
Driessen, Maurice T. |
|
|
23 |
1 |
|
artikel |
126 |
Real-world effectiveness of fremanezumab in migraine patients initiating treatment in the United States: results from a retrospective chart study
|
Driessen, Maurice T. |
|
|
23 |
1 |
|
artikel |
127 |
Real-World experience of interictal burden and treatment in migraine: a qualitative interview study
|
Lo, Siu Hing |
|
|
23 |
1 |
|
artikel |
128 |
Real-world experience with 240 mg of galcanezumab for the preventive treatment of cluster headache
|
Mo, Heejung |
|
|
23 |
1 |
|
artikel |
129 |
Real-world long-term efficacy and safety of erenumab in adults with chronic migraine: a 52-week, single-center, prospective, observational study
|
Cullum, Christopher Kjaer |
|
|
23 |
1 |
|
artikel |
130 |
Relative efficacy of lasmiditan versus rimegepant and ubrogepant as acute treatments for migraine: network meta-analysis findings
|
Polavieja, Pepa |
|
|
23 |
1 |
|
artikel |
131 |
Repeated inflammatory dural stimulation-induced cephalic allodynia causes alteration of gut microbial composition in rats
|
Miao, Shuai |
|
|
23 |
1 |
|
artikel |
132 |
Resting-state magnetoencephalographic oscillatory connectivity to identify patients with chronic migraine using machine learning
|
Hsiao, Fu-Jung |
|
|
23 |
1 |
|
artikel |
133 |
Resumption of migraine preventive treatment with CGRP(-receptor) antibodies after a 3-month drug holiday: a real-world experience
|
Raffaelli, Bianca |
|
|
23 |
1 |
|
artikel |
134 |
Safety and tolerability of erenumab in individuals with episodic or chronic migraine across age groups: a pooled analysis of placebo-controlled trials
|
Lampl, Christian |
|
|
23 |
1 |
|
artikel |
135 |
Serum CGRP in migraine patients using erenumab as preventive treatment
|
de Vries Lentsch, Simone |
|
|
23 |
1 |
|
artikel |
136 |
Similarities and differences between SUNCT and SUNA: a cross-sectional, multicentre study of 76 patients in China
|
Zhang, Shuhua |
|
|
23 |
1 |
|
artikel |
137 |
Single-Pulse Transcranial Magnetic Stimulation for the preventive treatment of difficult-to-treat migraine: a 12-month prospective analysis
|
Lloyd, J.O. |
|
|
23 |
1 |
|
artikel |
138 |
Sphingosine-1 phosphate receptor 1 contributes to central sensitization in recurrent nitroglycerin-induced chronic migraine model
|
Pan, Qi |
|
|
23 |
1 |
|
artikel |
139 |
Swiss QUality of life and healthcare impact Assessment in a Real-world Erenumab treated migraine population (SQUARE study): interim results
|
Gantenbein, Andreas R. |
|
|
23 |
1 |
|
artikel |
140 |
Synaptic alterations in visual cortex reshape contrast-dependent gamma oscillations and inhibition-excitation ratio in a genetic mouse model of migraine
|
Meneghetti, Nicolò |
|
|
23 |
1 |
|
artikel |
141 |
Temporal characteristics of astrocytic activation in the TNC in a mice model of pain induced by recurrent dural infusion of inflammatory soup
|
Zhang, Leyi |
|
|
23 |
1 |
|
artikel |
142 |
The applicability research of the diagnostic criteria for 6.7.2 angiography headache in the international classification of headache disorders-3rd edition
|
Lu, Chenglong |
|
|
23 |
1 |
|
artikel |
143 |
The bidirectional temporal relationship between headache and affective disorders: longitudinal data from the HUNT studies
|
Giri, Samita |
|
|
23 |
1 |
|
artikel |
144 |
The economic and personal burden of cluster headache: a controlled cross-sectional study
|
Petersen, Anja Sofie |
|
|
23 |
1 |
|
artikel |
145 |
The efficacy and safety of atogepant for the prophylactic treatment of migraine: evidence from randomized controlled trials
|
Tao, Xinyu |
|
|
23 |
1 |
|
artikel |
146 |
The Global Campaign turns 18: a brief review of its activities and achievements
|
Steiner, Timothy J. |
|
|
23 |
1 |
|
artikel |
147 |
The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates
|
Stovner, Lars Jacob |
|
|
23 |
1 |
|
artikel |
148 |
The headache registry of the German Migraine and Headache Society (DMKG): baseline data of the first 1,351 patients
|
Ruscheweyh, Ruth |
|
|
23 |
1 |
|
artikel |
149 |
The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence
|
Gollion, Cedric |
|
|
23 |
1 |
|
artikel |
150 |
The prevalence of primary headache disorders in children and adolescents in Zambia: a schools-based study
|
Kawatu, Nfwama |
|
|
23 |
1 |
|
artikel |
151 |
Time is of the essence in headache measurement. A response to Gil-Gouveia
|
Steiner, TJ. |
|
|
23 |
1 |
|
artikel |
152 |
TIME, to move forward? comment on “a universal outcome measure for headache treatments, care-delivery systems and economic analysis”
|
Gil-Gouveia, Raquel |
|
|
23 |
1 |
|
artikel |
153 |
Total tenderness score and pressure pain thresholds in persistent post-traumatic headache attributed to mild traumatic brain injury
|
Ashina, Håkan |
|
|
23 |
1 |
|
artikel |
154 |
Tracking the evolution of non-headache symptoms through the migraine attack
|
Messina, Roberta |
|
|
23 |
1 |
|
artikel |
155 |
Trends in utilization and costs of migraine medications, 2017–2020
|
Nguyen, Jennifer L. |
|
|
23 |
1 |
|
artikel |
156 |
Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia
|
KC, Elina |
|
|
23 |
1 |
|
artikel |
157 |
Twelve-month safety, tolerability and susceptibility to adverse events of prophylactic migraine therapy with erenumab: a retrospective real-world study
|
Schenk, Hannah |
|
|
23 |
1 |
|
artikel |
158 |
Two-year effectiveness of erenumab in resistant chronic migraine: a prospective real-world analysis
|
Andreou, Anna P. |
|
|
23 |
1 |
|
artikel |
159 |
Using natural language processing to automatically classify written self-reported narratives by patients with migraine or cluster headache
|
Vandenbussche, Nicolas |
|
|
23 |
1 |
|
artikel |
160 |
Variability in recurrence rates with acute treatments for migraine: why recurrence is not an appropriate outcome measure
|
Tepper, Stewart J. |
|
|
23 |
1 |
|
artikel |
161 |
Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks
|
Coppola, Gianluca |
|
|
23 |
1 |
|
artikel |
162 |
What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials
|
Woldeamanuel, Yohannes W. |
|
|
23 |
1 |
|
artikel |